PMC:7696151 / 72450-72562 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"2100","span":{"begin":30,"end":33},"obj":"Chemical"},{"id":"2101","span":{"begin":37,"end":44},"obj":"Chemical"}],"attributes":[{"id":"A2100","pred":"tao:has_database_id","subj":"2100","obj":"MESH:D006886"},{"id":"A2101","pred":"tao:has_database_id","subj":"2101","obj":"MESH:D001241"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"The addition of 400 mg/day of HCQ to aspirin resulted in a significant increase in aggregation inhibition (31%)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T461","span":{"begin":0,"end":112},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"The addition of 400 mg/day of HCQ to aspirin resulted in a significant increase in aggregation inhibition (31%)."}